These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 28701192

  • 21. Detoxified lethal toxin as a potential mucosal vaccine against anthrax.
    Xu Q, Zeng M.
    Clin Vaccine Immunol; 2008 Apr; 15(4):612-6. PubMed ID: 18256208
    [Abstract] [Full Text] [Related]

  • 22. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 23. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I, Bar-David E, Sittner A, Weiss S, Schlomovitz J, Ben-Shmuel A, Mechaly A, Altboum Z, Kobiler D, Levy H.
    Antimicrob Agents Chemother; 2016 Aug 01; 60(8):4878-85. PubMed ID: 27270276
    [Abstract] [Full Text] [Related]

  • 24. Progress and novel strategies in vaccine development and treatment of anthrax.
    Chitlaru T, Altboum Z, Reuveny S, Shafferman A.
    Immunol Rev; 2011 Jan 01; 239(1):221-36. PubMed ID: 21198675
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.
    FEMS Immunol Med Microbiol; 2012 Aug 01; 65(3):505-9. PubMed ID: 22515653
    [Abstract] [Full Text] [Related]

  • 26. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
    Peachman KK, Rao M, Alving CR, Burge R, Leppla SH, Rao VB, Matyas GR.
    Infect Immun; 2006 Jan 01; 74(1):794-7. PubMed ID: 16369043
    [Abstract] [Full Text] [Related]

  • 27. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino SI.
    Microbiology (Reading); 2006 Oct 01; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [Abstract] [Full Text] [Related]

  • 28. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
    Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharyya S, Blake MS, Kopecko DJ.
    Infect Immun; 2009 Apr 01; 77(4):1475-82. PubMed ID: 19179420
    [Abstract] [Full Text] [Related]

  • 29. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.
    Infect Immun; 2007 Apr 01; 75(4):1827-34. PubMed ID: 17145938
    [Abstract] [Full Text] [Related]

  • 30. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
    Marcus H, Danieli R, Epstein E, Velan B, Shafferman A, Reuveny S.
    Infect Immun; 2004 Jun 01; 72(6):3471-7. PubMed ID: 15155654
    [Abstract] [Full Text] [Related]

  • 31. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
    Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.
    Hum Vaccin; 2007 Jun 01; 3(3):90-3. PubMed ID: 17375001
    [Abstract] [Full Text] [Related]

  • 32. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A, Kumar M, Nagar DP, Pal V, Goel AK.
    Biologicals; 2019 Sep 01; 61():38-43. PubMed ID: 31416791
    [Abstract] [Full Text] [Related]

  • 33. Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits.
    Weiss S, Kobiler D, Levy H, Marcus H, Pass A, Rothschild N, Altboum Z.
    Infect Immun; 2006 Jan 01; 74(1):394-8. PubMed ID: 16368995
    [Abstract] [Full Text] [Related]

  • 34. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Henning LN, Carpenter S, Stark GV, Serbina NV.
    Antimicrob Agents Chemother; 2018 Feb 01; 62(2):. PubMed ID: 29133571
    [Abstract] [Full Text] [Related]

  • 35. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J, Cho M, Lee HR, Cha K, Chun JH, Hong KJ, Park J, Rhie GE.
    Biochim Biophys Acta; 2013 Mar 01; 1830(3):2804-12. PubMed ID: 23201204
    [Abstract] [Full Text] [Related]

  • 36. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL, Freilich DA, Brice GT, Burgess TH, Berzins MP, Bull RL, Graber NL, Dabbs JL, Shatney LL, Blazes DL, Bebris LM, Malone MF, Eisold JF, Mateczun AJ, Martin GJ.
    J Infect Dis; 2007 Jan 15; 195(2):174-84. PubMed ID: 17191162
    [Abstract] [Full Text] [Related]

  • 37. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK, Alex M, Czerny CP, Böhm R, Beyer W.
    Int J Med Microbiol; 2004 Jul 15; 294(1):35-44. PubMed ID: 15293452
    [Abstract] [Full Text] [Related]

  • 38. A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.
    Kachura MA, Hickle C, Kell SA, Sathe A, Calacsan C, Kiwan R, Hall B, Milley R, Ott G, Coffman RL, Kanzler H, Campbell JD.
    J Immunol; 2016 Jan 01; 196(1):284-97. PubMed ID: 26608924
    [Abstract] [Full Text] [Related]

  • 39. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.
    FEMS Immunol Med Microbiol; 2009 Nov 01; 57(2):165-72. PubMed ID: 19732139
    [Abstract] [Full Text] [Related]

  • 40. Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.
    Aloni-Grinstein R, Gat O, Altboum Z, Velan B, Cohen S, Shafferman A.
    Infect Immun; 2005 Jul 01; 73(7):4043-53. PubMed ID: 15972492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.